March 1, 2017 / 11:59 AM / 5 months ago

BRIEF-Eagle Pharmaceuticals posts Q4 earnings per share $3.52

1 Min Read

March 1 (Reuters) - Eagle Pharmaceuticals Inc

* Eagle Pharmaceuticals Inc reports fourth quarter and full year 2016 results

* Q4 earnings per share $3.52

* Q4 revenue $81.1 million versus I/B/E/S view $86 million

* Q4 earnings per share view $2.82 -- Thomson Reuters I/B/E/S

* Eagle Pharmaceuticals Inc - 2017 research and development expense is expected to be in range of $31 million - $35 million

* Eagle Pharmaceuticals Inc sees 2017 SG&A expense to be in range of $65 - $68 million

* Eagle Pharmaceuticals Inc - at year end, Eagle had purchased $37 million in Eagle common stock as part of its $75 million share repurchase program Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below